Literature DB >> 16009345

G-308A TNF-alpha polymorphism is associated with an increased risk of invasive cervical cancer.

Isabel Duarte1, Alexandra Santos, Hugo Sousa, Raquel Catarino, Daniela Pinto, Ana Matos, Deolinda Pereira, José Moutinho, Paulo Canedo, José Carlos Machado, Rui Medeiros.   

Abstract

Cervical cancer is initiated by high-risk human papillomaviruses (HPV-16 and HPV-18), but an effective immune response may control the progression of this disease. Tumor necrosis factor-alpha (TNF-alpha) is a pro-inflammatory cytokine, that has been implicated in several cancers. In a case-control study, we evaluated the association between the G-308A TNF-alpha promoter polymorphism and the risk for invasive cervical cancer (ICC). TNF-alpha polymorphism was analyzed by PCR-RFLP and confirmed by sequencing. DNA was obtained from blood samples of 439 individuals, including 195 patients with ICC and 244 normal healthy controls. According to our results, women carrying the A allele present a twofold increased risk of developing ICC (p=0.006; OR=1.88; 95% CI [1.20-2.94]). In conclusion, our study suggests that the presence of the high producer allele -308A in the TNF-alpha gene appears to be associated with an increased risk for the development of ICC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16009345     DOI: 10.1016/j.bbrc.2005.06.137

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  Polymorphisms in immune mediators associate with risk of cervical cancer.

Authors:  Zhengyan Zhang; Samantha Fye; Ingrid B Borecki; Janet S Rader
Journal:  Gynecol Oncol       Date:  2014-08-12       Impact factor: 5.482

2.  Study on the association of p53 codon 72 polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu Province in China.

Authors:  Zhu Ke-Xiang; Li Yu-Min; Li Xun; Zhou Wen-Ce; Shan Yong; Liu Tao
Journal:  Mol Biol Rep       Date:  2011-05-12       Impact factor: 2.316

3.  Gastric cancer in a Caucasian population: role of pepsinogen C genetic variants.

Authors:  Ana L Pinto-Correia; Hugo Sousa; Maria Fragoso; Luís Moreira-Dias; Carlos Lopes; Rui Medeiros; Mário Dinis-Ribeiro
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

4.  Study on the association of COX-2 genetic polymorphisms with risk of gastric cancer in high incidence Hexi area of Gansu province in China.

Authors:  Zhu Ke-Xiang; Li Yu-Min; Li Xun; Zhou Wen-Ce; Shan Yong; Liu Tao
Journal:  Mol Biol Rep       Date:  2010-04-04       Impact factor: 2.316

5.  Association of TNF-α and Fas gene promoter polymorphism with the risk of Kashin-Beck disease in Northwest Chinese population.

Authors:  Quan-ming Zhao; Xiong Guo; Jiang-hua Lai; Wu-hong Tan; Wei-zhuo Wang; Xiao-qian Dang
Journal:  Clin Rheumatol       Date:  2012-03-20       Impact factor: 2.980

6.  IL-1RN VNTR polymorphism and genetic susceptibility to cervical cancer in Portugal.

Authors:  Hugo Sousa; Alexandra M Santos; Raquel Catarino; Daniela Pinto; José Moutinho; Paulo Canedo; José Carlos Machado; Rui Medeiros
Journal:  Mol Biol Rep       Date:  2012-10-10       Impact factor: 2.316

Review 7.  Tumor necrosis factor and cancer, buddies or foes?

Authors:  Xia Wang; Yong Lin
Journal:  Acta Pharmacol Sin       Date:  2008-11       Impact factor: 6.150

8.  A systemic assessment of the association between tumor necrosis factor alpha 308 G/A polymorphism and risk of cervical cancer.

Authors:  Hua-Lian Zhang; Yi-Jie Zhang
Journal:  Tumour Biol       Date:  2013-03-15

Review 9.  Human Genetic Determinants of Viral Diseases.

Authors:  Adam D Kenney; James A Dowdle; Leonia Bozzacco; Temet M McMichael; Corine St Gelais; Amanda R Panfil; Yan Sun; Larry S Schlesinger; Matthew Z Anderson; Patrick L Green; Carolina B López; Brad R Rosenberg; Li Wu; Jacob S Yount
Journal:  Annu Rev Genet       Date:  2017-08-30       Impact factor: 16.830

10.  Tumour necrosis factor alpha 308 G/A is a risk marker for the progression from high-grade lesions to invasive cervical cancer.

Authors:  Hugo Sousa; Sara Oliveira; Alexandra M Santos; Raquel Catarino; José Moutinho; Rui Medeiros
Journal:  Tumour Biol       Date:  2013-11-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.